MA26544A1 - Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles - Google Patents

Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles

Info

Publication number
MA26544A1
MA26544A1 MA25244A MA25244A MA26544A1 MA 26544 A1 MA26544 A1 MA 26544A1 MA 25244 A MA25244 A MA 25244A MA 25244 A MA25244 A MA 25244A MA 26544 A1 MA26544 A1 MA 26544A1
Authority
MA
Morocco
Prior art keywords
elastase inhibitors
neutrophilic elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
MA25244A
Other languages
English (en)
Inventor
Dennis Dowle Michael
Finch Harry
Andrew Harrison Lee
George Adam Inglis Graham
John Fawcett Macdonald Simon
Redpath Johnson Martin
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26544A1 publication Critical patent/MA26544A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
MA25244A 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles MA26544A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9719187.8A GB9719187D0 (en) 1997-09-09 1997-09-09 Compounds

Publications (1)

Publication Number Publication Date
MA26544A1 true MA26544A1 (fr) 2004-12-20

Family

ID=10818820

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25244A MA26544A1 (fr) 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles

Country Status (24)

Country Link
US (1) US6228853B1 (fr)
EP (1) EP1019406A1 (fr)
JP (1) JP2001515902A (fr)
KR (1) KR20010023830A (fr)
CN (1) CN1278821A (fr)
AP (1) AP2000001760A0 (fr)
AU (1) AU9536098A (fr)
BR (1) BR9811651A (fr)
CA (1) CA2303249A1 (fr)
EA (1) EA200000205A1 (fr)
EE (1) EE200000137A (fr)
GB (1) GB9719187D0 (fr)
HR (1) HRP20000136A2 (fr)
HU (1) HUP0003475A3 (fr)
ID (1) ID24364A (fr)
IL (1) IL134935A0 (fr)
IS (1) IS5394A (fr)
MA (1) MA26544A1 (fr)
NO (1) NO20001200L (fr)
PL (1) PL339186A1 (fr)
SK (1) SK3242000A3 (fr)
TR (1) TR200001026T2 (fr)
WO (1) WO1999012931A1 (fr)
ZA (1) ZA988162B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
US7745226B2 (en) * 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
US7972868B2 (en) 2007-11-28 2011-07-05 Quest Diagnostics Investments Incorporated Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
US7977117B2 (en) 2009-12-03 2011-07-12 Quest Diagnostics Investments Incorprated Vitamin D metabolite determination utilizing mass spectrometry following derivatization
JP5739903B2 (ja) 2009-12-11 2015-06-24 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド 複合試料中のステロイド化合物の質量分析
CN102753964A (zh) 2009-12-11 2012-10-24 奎斯特诊断投资公司 非衍生的、非代谢的维生素d的质谱测定
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HUE064089T2 (hu) 2020-04-16 2024-02-28 Mereo Biopharma 4 Ltd Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983245A (en) 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes
GB8512230D0 (en) * 1985-05-14 1985-06-19 Shell Internationale Researche Preparation of carboxylic acid salt
GB9211783D0 (en) 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US6020368A (en) * 1996-01-03 2000-02-01 Hinks; Jeremy David Carbamoyloxy derivatives of mutiline and their use as antibacterials
IL125859A0 (en) 1996-03-28 1999-04-11 Glaxo Group Ltd Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
NO20001200D0 (no) 2000-03-08
HRP20000136A2 (en) 2000-08-31
JP2001515902A (ja) 2001-09-25
US6228853B1 (en) 2001-05-08
CN1278821A (zh) 2001-01-03
CA2303249A1 (fr) 1999-03-18
ID24364A (id) 2000-07-13
EA200000205A1 (ru) 2000-10-30
NO20001200L (no) 2000-05-08
EE200000137A (et) 2001-02-15
BR9811651A (pt) 2000-08-08
KR20010023830A (ko) 2001-03-26
WO1999012931A1 (fr) 1999-03-18
PL339186A1 (en) 2000-12-04
AU9536098A (en) 1999-03-29
EP1019406A1 (fr) 2000-07-19
ZA988162B (en) 2000-03-22
IS5394A (is) 2000-03-03
AP2000001760A0 (en) 2000-03-31
SK3242000A3 (en) 2001-03-12
HUP0003475A3 (en) 2002-01-28
IL134935A0 (en) 2001-05-20
TR200001026T2 (tr) 2000-09-21
HUP0003475A2 (hu) 2001-09-28
GB9719187D0 (en) 1997-11-12

Similar Documents

Publication Publication Date Title
FR2725204B1 (fr) 2-hydroxyphenyltriazines comme agents photostabilisants
FR07C0057I2 (fr) Derives de pleuromutiline utilises comme agents antimicrobiens
EP0636141A1 (fr) Acetamides de pyrimidinyle utilises comme inhibiteurs d'elastase.
NL350032I2 (nl) Pyrazool-4-yl-benzoylderivaten de toepassing ervanals herbiciden
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
MA26816A1 (fr) Derives d'amino-triazolopyridine
ID16866A (id) Kompleks kompleks inklusi garam-garam aril-heterosiklik
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DK0991658T3 (da) Dolastatin 15-derivater
FR2748027B1 (fr) Derives de la fluoresceine 4'-methyl-substituee
MA26543A1 (fr) Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles.
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
FR2763953B1 (fr) Derives de 5'-desoxy-cytidine
DE69736109D1 (de) Differenzierungsinhibitor
BR9509793A (pt) Derivados de tiofeneno
DE69702001D1 (de) Beschichtungszusammensetzungen
EP1046648A4 (fr) Derives de 3'-desoxyribonucleotide
EE03615B1 (et) Pürasool-4-üülhetaroüülderivaadid herbitsiididena
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
PT1060183E (pt) Derivados de 5'-desoxicitidina
MA26480A1 (fr) Derives de phenoxymethylpiperidine
DE69625500D1 (de) Achselzusammensetzungen
BR9709521A (pt) "3-Cianoaril-pirazóis"
DE69523521D1 (de) Überzugsmittel-Zusammensetzungen